The use of leucocytic marker CD45 for negative selection combined with immunofluorescence staining methods that use antibodies against N-cadherin, CD133, and multi-cytokeratin was also employed for the detection of CTCs in HNSCC (30). This evidence concerns the gene PTPRC and head and neck squamous cell carcinoma.